Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > CBD skin care market to reach $3,484m with a CAGR of 24.80%

<< Previous

Bullboard Posts

Next >>

Comment by Righttothetopon Feb 18, 2021 9:20am

104 Views

Post# 32594163

RE:CBD skin care market to reach $3,484m with a CAGR of 24.80%

Honestly I think that number is understated.....beyond CBD being the new 'IT' thing, once studies come out to confirm some kind of efficacy, CBD based products just become another product that people can buy....I expect if positive results come out, $3bil becomes a global quarter.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland